Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
The Effect of Maternal Folic Acid Supplementation on Neurodevelopmental Disorders in Offspring: An Umbrella Review of
Miao Yu1,2, Yiming Hu2, Lei Hou2
1School of Public Health, Inner Mongolia Medical University, Hohhot 010110, China.
Insights
Maternal folic acid supplementation may lower the risk of autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and behavioral problems in children. While evidence quality is low, benefits for neural tube defects (NTDs) support continued supplementation.
Area of Science:
- Obstetrics and Gynecology
- Neuroscience
- Public Health
Background:
- Maternal folic acid supplementation is crucial for preventing neural tube defects (NTDs).
- The impact of prenatal folic acid on offspring neurodevelopmental disorders (NDDs) requires further clarification.
- Existing evidence synthesis on folic acid and NDDs is fragmented.
Purpose of the Study:
- To conduct an umbrella review evaluating the association between maternal folic acid supplementation and offspring NDDs.
- To synthesize evidence from systematic reviews and meta-analyses on this topic.
- To assess the quality and certainty of the available evidence.
Main Methods:
- Systematic search of major databases (MEDLINE, Cochrane Library, EMBASE, PubMed, Web of Science) up to June 2025.
- Inclusion of systematic reviews and meta-analyses of non-randomized studies.
- Quality assessment using AMSTAR-2 and evidence certainty using GRADE framework.
Main Results:
- 23 systematic reviews/meta-analyses were included; many had methodological limitations.
- Meta-analyses suggested a protective effect: OR 0.66 for ASD, 0.86 for ADHD, 0.75 for behavioral problems.
- No significant associations found for motor, intellectual/cognitive, or language development; conclusions were inconsistent across reviews.
Conclusions:
- Maternal folic acid supplementation may reduce the risk of ASD, ADHD, and behavioral problems.
- Current evidence is of low quality, necessitating further research.
- Supplementation is justified due to established NTD prevention benefits.
Abstract:
Objectives: Maternal folic acid supplementation is recommended to prevent neural tube defects (NTDs), yet its influence on offspring neurodevelopmental disorders (NDDs) remains uncertain. This umbrella review aims to evaluate whether maternal folic acid supplementation before and/or during pregnancy affects the risk of NDDs. Methods: We conducted a systematic search in MEDLINE, Cochrane Library, EMBASE, PubMed, and Web of Science from inception to 30 June 2025, to identify systematic reviews (SRs) and meta-analyses (MAs) that synthesized evidence from non-randomized studies on maternal folic acid supplementation and NDDs. Methodological quality was assessed using the AMSTAR-2 assessment and evidence certainty using the GRADE framework. Results: A total of 23 SRs/MAs were included, of which 14 did not perform meta-analysis. Most included SRs/MAs were methodologically limited, with 50.00% rated as very low quality and only 36.37% achieving high or moderate quality. MAs indicated a protective effect of supplementation, with odds ratio (OR) of 0.66 (95% confidence interval (CI): 0.55-0.79) for autism spectrum disorder (ASD), 0.86 (95% CI: 0.78-0.95) for attention-deficit/hyperactivity disorder (ADHD), and 0.75 (95% CI: 0.63-0.91) for behavioral problems. No significant associations were found for motor, intellectual/cognitive, or language development. SRs reported inconsistent conclusions across most outcomes. Conclusions: In summary, maternal folic acid supplementation may reduce the risk of ASD, ADHD, and behavioral problems in offspring. Although the current evidence is of low quality, supplementation guidelines are justified by the well-established benefits for NTDs. Further research is required to address remaining uncertainties.
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
Related Concept Videos
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Vitamins